| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99199 |
Unlisted special service, procedure or report |
78,137 |
47,895 |
$457K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,154 |
4,851 |
$377K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,071 |
2,868 |
$311K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,897 |
1,595 |
$198K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
648 |
441 |
$139K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,480 |
1,139 |
$116K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,414 |
1,752 |
$87K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,731 |
2,790 |
$81K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
918 |
670 |
$68K |
| 99215 |
Prolong outpt/office vis |
751 |
478 |
$63K |
| 69210 |
|
3,006 |
1,750 |
$62K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,483 |
3,447 |
$52K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
585 |
452 |
$51K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
998 |
766 |
$42K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
958 |
696 |
$29K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,517 |
1,106 |
$24K |
| 87807 |
|
2,189 |
1,363 |
$24K |
| 92583 |
|
1,077 |
891 |
$22K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
562 |
411 |
$17K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
632 |
450 |
$12K |
| 86308 |
|
2,721 |
1,583 |
$10K |
| D0145 |
Oral evaluation for a patient under three years of age |
316 |
233 |
$9K |
| 94150 |
|
800 |
448 |
$7K |
| 92551 |
|
2,244 |
1,735 |
$7K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,056 |
697 |
$7K |
| D1206 |
Topical application of fluoride varnish |
331 |
245 |
$4K |
| 96127 |
|
1,195 |
681 |
$4K |
| 96160 |
|
1,190 |
729 |
$4K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
47 |
28 |
$4K |
| 99406 |
|
354 |
268 |
$4K |
| 99173 |
|
3,478 |
2,565 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
404 |
271 |
$2K |
| 94664 |
|
272 |
200 |
$2K |
| 83013 |
|
54 |
27 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
65 |
49 |
$2K |
| 99383 |
|
24 |
12 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
792 |
567 |
$2K |
| 97803 |
|
132 |
111 |
$2K |
| 99051 |
|
228 |
77 |
$1K |
| 92552 |
|
332 |
182 |
$712.10 |
| 90670 |
|
241 |
158 |
$367.68 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
20 |
12 |
$231.42 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
19 |
14 |
$142.52 |
| 90710 |
|
106 |
75 |
$10.00 |
| 90633 |
|
101 |
79 |
$10.00 |
| 36416 |
|
1,313 |
629 |
$6.32 |
| G9920 |
Screening performed and negative |
1,123 |
791 |
$0.00 |
| 1160F |
|
1,102 |
790 |
$0.00 |
| 90734 |
|
69 |
50 |
$0.00 |
| 90461 |
|
374 |
236 |
$0.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
206 |
201 |
$0.00 |
| 90700 |
|
18 |
12 |
$0.00 |
| 99188 |
|
57 |
15 |
$0.00 |
| 3078F |
|
880 |
634 |
$0.00 |
| 90715 |
|
49 |
29 |
$0.00 |
| 90671 |
|
16 |
13 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
332 |
238 |
$0.00 |
| 3008F |
|
1,159 |
798 |
$0.00 |
| 2001F |
|
1,237 |
845 |
$0.00 |
| 90656 |
|
46 |
42 |
$0.00 |
| 3074F |
|
881 |
635 |
$0.00 |
| 94760 |
|
68 |
37 |
$0.00 |
| 90688 |
|
156 |
121 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
17 |
17 |
$0.00 |
| 90651 |
|
17 |
16 |
$0.00 |